A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF CHARAKOKTA MUTRAVIRECHANIYA MAHAKASHAYA IN MUTRAKRICHRA OR LOWER URINARY TRACT INFECTION by Aryamol A D et al.
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
     IJAPR | August 2020 | Vol 8 | Issue 8  39 
International Journal of Ayurveda  
and Pharma Research 
 
Research Article 
 
A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFECT OF CHARAKOKTA 
MUTRAVIRECHANIYA MAHAKASHAYA IN MUTRAKRICHRA OR LOWER URINARY TRACT INFECTION 
Aryamol A D1*, Umesh C2, Gopal Krishna G3 
*1P.G. Scholar, 2Professor, 3Professor & HOD, Department of Kayachikitsa, Sri Sri College of Ayurvedic 
Science and Research, Bengaluru, Karnataka, India. 
ABSTRACT 
Mutrakrichra the disease of Mutravaha Srotas is caused due to Sanga (obstruction). 
Mutrakrichra means difficulty in micturition. Mutrakrichra can be compared to lower 
urinary tract infection (LUTI) symptoms. LUTI is the most common infection known to 
mankind and a common condition seen in general practice. Urinary tract infection affects 
more than 150 million people every year worldwide. Objective: To evaluate the effect of 
Mutravirechaniya Mahakashaya in LUTI and to compare its efficacy with Tab. Norfloxacin. 
Methods: 45 patients of either gender with the symptoms of LUTI were randomized into 
three groups of 15 patients each. Group A- received Mutravirechaniya Mahakashaya 50ml. 
Group B- received Tab. Norfloxacin 400mg and Group C- Mutravirechaniya Mahakashaya and 
Tab. Norfloxacin in the above mentioned dose for ten days. Efficacy outcomes were assessed 
through subjective parameters and routine urine and microscopic examination. 
Observation and results: When compared all the groups showed better results in relieving 
the clinical symptoms of LUTI. Overall patients treated with Mutravirechaniya Mahakashaya 
and Tab. Norfloxacin showed better results, but there was no significant difference between 
the groups (P<0.351). Conclusion: Mutravirechaniya Mahakashaya was able to meet the 
efficacy outcomes measures in comparison to Tab. Norfloxacin. Clinical effects of 
Mutravirechaniya Mahakashaya were similar to Tab. Norfloxacin owing to its diuretic, 
analgesic and anti-inflammatory properties. 
KEYWORDS: Ayurveda, Lower urinary tract infection, Mutrakrichra, Mutravirechaniya 
Mahakashaya, Norfloxacin. 
INTRODUCTION 
Dosha dhathu mala mulam hi shareeram, 
Dosha, Dhathu and Mala are the basic substratum of 
the Shareera (Body).[1] Mala being one among them, 
Acharyas have given importance to their function 
and their different status in the body. Mutra is one 
among the Trimala[2] and it plays a major role in 
Kledavahana. Mutravega is one among the 
Adharaniya Vegas[3]. Basti which is the Srotomula of 
the Mutra is one among the Trimarma[4]. All these 
factors highlight the importance of the Mutra. 
Disorders related to Mutra have been 
elaborately explained by our Acharyas and 
Mutrakrichra is one among them. As the word itself 
denotes, it is characterized by Kruchratha in 
Mutravahana (difficulty in micturition). The 
Samanya Lakshana of Mutrakrichra has been 
mentioned in Madhukosha commentary of Madhava 
Nidana as Kruchrarata in Mutravahana i.e. difficulty 
in micturition.[5] Other Lakshanas of Mutrakruchra 
varies according to the predominance of Dosha 
involved in pathogenesis like Shula (pain) in Vataja 
Mutrakrichra, Daha (burning sensation)in Pittaja 
Mutrakrichra and Gourvata (heaviness) in Kaphaja 
Mutrakrichra as predominant symptoms.  
Lower urinary tract infection (LUTI) is the 
most common infection seen in general practice. In 
majority of LUTI, bacteria establish infection by 
ascending from urethra to bladder. The entry of 
uro-pathogens in to the urinary tract is often from 
peri-urethral colonisation in females and from 
preputial colonisation in uncircumcised males. 
Escherichia Coli and Staphylo Saprophyticus are the 
most common organisms involved in causing 
LUTI.[6] Patients with LUTI present with symptoms 
such as abrupt onset of frequency of urination and 
urgency, dysuria- burning pain in urethra during 
micturition, nocturia, urge incontinence, suprapubic 
pain, sensation of incomplete bladder emptying due 
to spasm of inflamed bladder wall, urine having 
offensive smell, blood and cloudy appearance.[7] 
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Mutravirechaniya Mahakashaya Gana is 
mentioned by Acharya Charaka, under Shad 
virechanashataashreetiya adhyaya.[8] The 
combination includes- Vrukshadhani (Dendropthoe 
falcate ainn. F.), Swadanshtra (Tribulus terrestris), 
Vasuka (Osmanthus fragrans), Apamarga 
(Achyranthus aspera), Pashanabheda (Aerva lanata 
Juss.), Darbha (Imperata cylindrical Beau.), Kusha 
(Desmostachya bipinnata stapf.), Kasha (Saccharum 
spontaneum Linn.), Gundra (Typha elephentina 
Roxb.) and Itkatamula (Sesbania cannabina). Most 
of these drugs possess Mutrakruchrahara (relives 
symptoms of LUTI) and Mutrala (diuretic) property. 
Vrukshadhani, Swadanshtra and Pashanabheda has 
got anti-bacterial activity.  
Norfloxacin belongs to the first-generation 
fluoroquinolones. Fluoroquinolones are basically 
quinolones antimicrobial and they have one or 
more fluorine substitution. Norfloxacin is primarily 
used for urinary and genital tract infection.[9] 
Hence the present study was intended to 
evaluate and compare the efficacy of 
Mutravirechaniya mahakashaya and Norfloxacin in 
Mutrakrichra vis-a-vis lower urinary tract infection.  
MATERIALS AND METHODS 
The study was a simple randomized 
controlled clinical study having three parallel arms 
(allocation ratio 1:1:1). Subjects diagnosed with 
Mutrakrichra or LUTI were recruited from OPD, IPD 
and special camps conducted at Sri Sri College of 
Ayurvedic Science and Research Hospital, 
Bengaluru. The ethical clearance from the 
institutional ethical committee was obtained prior 
to the initiation of the research. 
Eligibility Criteria: 
Inclusion criteria: 
Subjects aged between 18 to 70 years 
Subjects presenting with one or more of the 
following symptoms of LUTI: 
 Pain in lower abdomen 
 Increased frequency of urination 
 Burning micturition 
 Pain during micturition 
Subjects willing to give informed consent 
Exclusion Criteria 
 Subjects suffering from urinary calculi, 
pyelonephritis 
 Subjects suffering from benign prostatic 
hypertrophy, prostatitis 
 Subjects suffering from diabetes mellitus and 
sexually transmitted diseases 
 Pregnant women 
 Subjects who have participated in clinical trials 
within 6 months. 
 
Diagnostic Criteria 
 Diagnosis was established based on the 
signs and symptoms of Mutrakrichra and LUTI 
further confirmed with laboratory investigation- 
Urine routine and microscopy for presence of 
bacteria and pus cells.  
Intervention 
 Group A- Patients were given Mutravirechaniya 
Mahakashaya 50ml, twice a day along with 
warm water, before food for 10 days. 
 Group B- patients were given Tab. Norfloxacin 
400mg 1 bid, after food for 10 days. 
 Group C- Patients were given both 
Mutravirechaniya Mahakashaya and Tab. 
Norfloxacin 400mg with above mentioned 
dosage respectively for 10 days. 
Assessment criteria 
Subjective criteria  
Pain in the lower abdomen 
a. Grade 0 (normal- absent) 
b. Grade 1 [mild- present but intensity is less 
(draws attention)] 
c. Grade 2 (moderate- present, intensity is high, 
able to do routine activities) 
d. Grade 3 (severe- present, intensity is severe- 
not able to do routine activities) 
Frequency of Urination 
a. Grade 0- less than 5 times 
b. Grade 1- 5-8 times 
c. Grade 2- 8-12 times 
d. Grade 3- more than 12 times 
Burning Sensation 
a. Grade 0- absent 
b. Grade 1/ mild- occasional mild burning 
c. Grade 2/ moderate- moderate burning with 
every voiding 
d. Grade 3/ severe- severe burning with every 
voiding 
Pain During Urination 
a. Grade 0- absent 
b. Grade 1/ mild- occasional mild pain 
c. Grade 2/ moderate- often moderate pain 
d. Grade 3/severe- severe pain 
Objective Criteria  
Urine microscopy was done before treatment and 
after the treatment (11th day) 
Urine Microscopy 
Pus cells 
1. Grade 0- 0- 5/hpf 
2. Grade 1- 5-15/hpf 
3. Grade 2- 15-25/hpf 
4. Grade 3- 25-35/hpf 
5. Grade 4- 35-45/hpf  
6. Grade 5- 45-55/hpf 
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Bacteria 
1. Grade 0- absent 
2. Grade 1- present 
Assessment schedule 
 Data was collected before treatment (0th 
day), on 5th day, 11th day (after completion of 
treatment) and 15th day (follow up). Urine routine 
and microscopy was done on 0th day and 11th day.  
Statistical Analysis 
 The statistical analysis was done using the 
SPSS software version 20. Paired t -test and ANOVA 
test were applied to analyze parametric data within 
and between the groups. Wilcoxon signed rank test 
and Kruskall wall is test was applied to analyze non 
parametric data within and between the groups 
respectively. 
OBSERVATIONS 
 Maximum incidence of Mutrakrichra was 
noticed in the age group of 18-29 years followed by 
60-69 years. LUTI is most commonly seen in 
patients of reproductive and sexually active 
individuals. The same might be the reason for the 
incidence of Mutrakrichra in 18-29 years of age 
group in the study. Urinary incontinence is most 
commonly seen in elderly due to weak bladder 
muscles leading to lower urinary tract infection. 
The incidence of disease in different age group in 
the present study is shown in Table No. 1. 
In the present study, incidence of gender 
showed that females were more prone to LUTI. The 
reasons behind this are short urethra and nearby 
structures like vagina and anus. Other than these 
reasons, Mutravegadharana (suppression of urge to 
micturate) was noticed in most of the female. 
Unhygienic toilet facilities in public places and work 
places might be the reason behind Vegadharana. 
The incidence of disease based on gender is given in 
Table No. 2.  
Maximum number of patients had moderate 
physical activities with reduced water intake. Water 
intake disproportionate to physical activity was 
noticed, this might be the cause for dehydration, 
contributing to lower urinary tract infection. The 
physical activity and water intake of the patients in 
present study is given in Table No. 3 and 4.  
Table 1: Showing the incidence of disease with relation to age 
Age Group A Group B Group C Total 
18-29 6 6 3 15 (33.33%) 
30-39 2 2 6 10 (22.22%) 
40-49 1 0 1 2 (4.44%) 
50-59 2 3 2 7 (15.50%) 
60-69 4 4 3 11 (24.44%) 
Table 2: Showing the incidence of disease with relation to gender 
Gender  Group A Group B Group C Total 
Female  15 15 13 43(95.50%) 
Male  0 0 2 2 (4.40%) 
Table 3: Showing the incidence of disease with relation to physical activity 
Physical activity Group A Group B Group C Total 
Sedentary  2 0 1 3(6.60%) 
Moderate  12 12 9 33 (73.33%) 
Vigorous  1 3 5 9 (20%) 
Table 4: Showing the incidence of disease with relation to water intake 
Water intake (per day) Group A Group B Group C Total 
1 litre 5 4 7 16 (35.55%) 
2 litres 7 10 7 24 (53.33%) 
3 litres 2 1 1 4 (8.88%) 
4 litres 1 0 0 1 (2.22%) 
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Subject flow chart through the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enrolment 
Consecutively assessment of subjects based on 
subjective objective criteria in the age group 
between 18-70 years 
 
Randomized (n=48) 
 Excluded (n=0) 
 Not meeting inclusion criteria (n=0) 
 Declined to participate (n=0)  
 Other reasons (n=) 
 
Allocated to controlled intervention 
(n=17) 
 N=15 received the standard drug 
 N= 2 did not receive allocated 
intervention as they dropped out 
due to symptoms of acidity after 
intake of Kashayam 
Allocated to trial intervention 
(n=16) 
 N=15 received the trial drug  
 n=1 did not receive allocated 
intervention as they were 
lost to follow up. 
 
Allocated to trial 
intervention (n=15) 
 N=15 received the 
trial drug  
 n= 0 
Lost to follow up n=0 
Discontinued intervention n=2 
Analysed (n= 1 5 )  
Excluded from analysis due 
to missing data (n=2)  
Allocation (1:1:1) 
Follow- up 
 
Lost to follow up n=1 
Discontinued 
intervention n=0 
Lost to follow-up n=0 
Discontinued intervention n=0 
 
Analysis 
Analysed (n=15)  
Excluded from analysis due to 
missing data (n=1 )  
Analysed (n=15) 
Excluded from 
analysis due to 
missing data (n=0) 
 
Aryamol A D et al. The Effect of Charakokta Mutravirechaniya Mahakashaya in Mutrakrichra 
     IJAPR | August 2020 | Vol 8 | Issue 8  43 
Analysis of the result of drugs within the 
groups, for pain in lower abdomen group B and C 
had significant result with a p value of 0.020, for 
increased frequency of urination group A and group 
C had significant result with a p value of 0.010 and 
0.014 respectively, in burning sensation while 
urination, group A and C showed highly significant 
result with a p value of 0.001, in pain while 
urination group A showed significant result with a p 
value of 0.041. In objective parameters, in pus cells 
group B and C showed highly significant result with 
a p value of 0.005, in bacteria all the three groups 
showed statistically significant result with a p value 
of 0.000. The mean score with p value of group A, B 
and C are given in Table No. 5, 6 and 7 respectively.  
On comparing the results between the 
groups, there was no statistically significant result 
in the subjective parameter. By analysing the mean 
value, group A had highest mean value in all the 
subjective parameters when compared to group B 
and C. The mean score with p value on comparing 
the results in between the group is shown in Table 
No. 8. In objective parameter, there was no 
statistical significance for pus cells with a p value of 
0.269, whereas there was significant result for 
presence of bacteria in urine with a p value of0.000. 
Though, clinically faster recovery and sustained 
therapeutic effect was better in group C compared 
to group A and B. This can be considered as an add-
on effect of Mutravirechaniya Mahakashaya. 
Table 5: Showing the effect of medicine on subjective and objective criteria of group A 
Symptoms   Mean score P value  
B.T AT 
Pain in lower abdomen .27 .00 0.157 
Increased frequency of urination .87 .07 0.010 
Burning sensation while urination  1.93 .13 0.001 
Pain while urination  .73 .07 0.041 
Bacteria  1.00 0.40 0.000 
Pus cells 2.20 1.27 0.005 
Table 6: Showing the effect of medicine on subjective and objective criteria of group B 
Symptoms   Mean score P value  
BT AT 
Pain in lower abdomen .80 .07 0.020 
Increased frequency of urination .33 .00 0.102 
Burning sensation while urination  4.00 .00 0.016 
Pain while urination  .33 .13 0.180 
Bacteria  1.00 0.20 0.000 
Pus cells 2.47 0.80 0.000 
Table 7: Showing the effect of medicine on subjective and objective criteria of group C 
Symptoms   Mean score P value  
BT AT 
Pain in lower abdomen .73 .00 .020 
Increased frequency of urination .80 .00 .014 
Burning sensation while urination  1.80 .07 0.001 
Pain while urination  .13 .00 .157 
Bacteria  1.00 0.13 0.000 
Pus cells 2.47 0.80 0.000 
Table 8: showing the effect of medicine in between the groups 
Subjective criteria  Group A Group B Group C 
Pain in lower abdomen Mean  22.50 24.00 22.50 
P value  .368 
Increased frequency of 
urination 
Mean  24.00 22.50 22.50 
P value  .368 
Burning sensation 
while urination 
Mean  23.93 22.60 22.47 
P value  .470 
Pain while urination  Mean  23.00 22.50 21.50 
P value  .351 
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DISCUSSION ON RESULTS 
Pain in Lower Abdomen 
All the groups showed significant result on 
the symptom pain in lower abdomen. Most of the 
drugs in Mutravirechaniya Mahakashaya possess 
vatahara.[10-12], anti- inflammatory effect[13] and 
spasmolytic effect[14]. This might be the reason 
behind the relief of symptom in group A. 
Norfloxacin being an antibiotic has bactericidal 
effect and thus helps in LUTI which reduces cystitis. 
The combined effect of Mutravirechaniya 
Mahakashaya and Norfloxacin reduced the 
symptom in group C.  
Increased frequency of urination 
The drugs in Mutravirechaniyagana like 
Tribulus terrestris[15], Achyranthus aspera[14], Aerva 
lannata[16] and Saccharum spontaneum[17] has got 
diuretic activity. Diuretic activity of the drugs helps 
in flushing out the bacteria and thus reducing 
sensitivity of bladder. Norfloxacin primarily being 
an antibiotic brings down the infection of lower 
urinary tract, this subsides the increased frequency 
of urination. The combined effect of 
Mutravirechaniya Mahakashaya and Norfloxacin 
effectively relieved this symptom in group C. 
Burning Sensation While Urination 
Most of the drugs in Mutravirechaniya 
Mahakashaya like Dendroupthoe falcate [18], Tribulus 
terristris[15], Achyranthus aspera[14] Aerva lannata[16] 
has got diuretic effect. Increased amount of urine 
output reduces the concentration of urine thus 
relieving the burning sensation while urination. 
Norfloxacin possesses bactericidal activity. 
Infection being the cause for symptoms in the 
diseases, with bactericidal activity of Norfloxacin, 
burning sensation will come down. The combined 
effect of Mutravirechaniya Mahakashaya and 
Norfloxacin relieved this symptom effectively in 
group C. 
Pain while Urination 
In Mutravirechaniya Mahakashaya gana, 
there are drugs which have got analgesic and anti-
inflammatory activity. Aerva lannata[16], Typha 
elephentina[19] and Achyranthus aspera[14] has got 
analgesic effect. Tribulus terrestris[15], Achyranthus 
aspera[14], Aerva lannata[16] and Saccharum 
spontaneum[13] has got anti-inflammatory effect. 
This might be the reason behind for relief of 
symptom pain during urination after the intake of 
Kashaya. Norfloxacin, reduces the inflammation of 
lower urinary tract, thus reducing the symptom 
pain while urination. The combined effect of the 
Kashaya and Norfloxacin relieved the symptom 
effectively in group C.  
 
Bacteria in Urine 
In Mutravirechaniya Mahakashaya gana, 
most of the drugs like Dendropthoe falcate[18], 
Tribulus terrestris[15], Achyranthus aspera[14], Aerva 
lannata[16] has got antibacterial activity. This might 
be the reason for absence of bacteria in urine 
microscopy after the intake of medicine. 
Norfloxacin, inhibits the enzyme bacterial DNA 
synthesis, by binding to the enzyme-DNA 
complex.[8] The antibacterial activity of Norfloxacin 
along with the antibacterial, diuretic and anti-
inflammatory activity of Mutravirechaniya 
Mahakashaya acted well against the bacteria, thus 
bringing down the infection effectively in group C.  
Pus cells in urine 
Most of the drugs in Mutravirechaniya 
Mahakashaya possess antibacterial and diuretic 
activity it reduces the number of pus cells. 
Norfloxacin is an antibiotic which has bactericidal 
activity. As the infection reduces the number of pus 
cells also reduces. The anti-inflammatory activity of 
the drugs in Mutravirechaniya Mahakashaya also 
helps in bringing down the pus cells. The diuretic 
effect flushes out the bacteria and pus cells.  
On follow up on 15th day, group C showed 
statistically better results when compared to group 
A and B. This indicates that, Tablet Norfloxacin 
when taken along with Mutravirechaniya 
Mahakashaya, helped in effective management and 
prevention of further recurrence of infection.  
CONCLUSION 
Drug resistance and recurrence are 
common in LUTI. There was better recovery and 
sustained therapeutic effect in patients treated with 
Mutravirechaniya Mahakashaya and Tab. 
Norfloxacin but there were no statistically 
significant results between the groups. Over all it 
can be concluded that, in subjective parameter, the 
subjects treated with Mutravirechaniya 
Mahakashaya had better results compared to 
subjects treated with Norfloxacin and 
Mutravirechaniya Mahakashaya along with 
Norfloxacin. In objective parameter, subjects 
administered with Norfloxacin and 
Mutravirechaniya Mahakashaya along with 
Norfloxacin showed better result.  
ACKNOWLEDGEMENT 
We thank Sri Sri Tattva Pvt. Ltd Bangalore 
India for providing the drugs of Mutra virechaniya 
Mahakashaya free of cost. This research has 
however received no special grant from funding 
Aryamol A D et al. The Effect of Charakokta Mutravirechaniya Mahakashaya in Mutrakrichra 
     IJAPR | August 2020 | Vol 8 | Issue 8  45 
agencies in public, commercial or not-for-profit 
sectors. 
REFERENCES 
1. Priyavrath Sharma. Commentary: Nibhandas 
anghravyakya of dalhana on Nidhanasthana and 
Nyayachandrika of gayadasa on sutra sthana of 
Sushrutha, Vol I. Varanasi; Chowkhambha 
Sanskrit Series; 2014. p.153  
2. Brahmanand Tripathi. Astanga Hridayam of 
Vagbhata. Sutrasthana. Delhi; Chaukamba 
Sanskrit Pratishthan; 2017. p.11. 
3. Brahmanand Tripathi. Astanga Hridayam of 
Vagbhata. Sutrasthana. Delhi;Chaukamba 
Sanskrit Pratishthan; 2017. p.54. 
4. Yadavaji Trikamaji (editor). Commentary: 
Ayurveda Deepika of Chakrapani on Charaka 
Samhita of Charaka. Chikitsasthana. Varanasi; 
Chowkhambha Sanskrit Series; 2006. p.597 
5. Brahmanand Tripathi. Commentry: Madhukosha 
of Vijayarakshita and Srikanthadatta. Varanasi: 
Chaukamba Subharati Prakashan; 2007. p. 620 
6. Y.P.Munjal. API Textbook of Medicine. Jaypee 
Brothers Medical Publishers (P) Ltd. New Delhi; 
2015. p. 1791-1792 
7. Y.P.Munjal. API Textbook of Medicine. Jaypee 
Brothers Medical Publishers (P) Ltd. New Delhi; 
2015. p. 1792 
8. Yadavaji Trikamaji (editor). Commentary: 
Ayurveda Deepika of Chakrapani on Charaka 
Samhita of Charaka. Varanasi: Chowkhambha 
Sanskrit Series; 2006. p.33 
9. Tripathi, K D. Essentials of medical 
pharmacology. 8th Ed. New Delhi:Jaypee 
Brothers Medical Publishers; 2008. p.650 
10. K.C.Chunekar. Bhavaprakasha of Bhavamishra. 
Volume 1.Varanasi; Chowkamba Sanskrit Series 
Office; 2004. p. 414 
11. K.C.Chunekar. Bhavaprakasha of Bhavamishra. 
Volume 1. Varanasi: Chowkamba Sanskrit Series 
Office; 2004. p. 104 
12. K.C.Chunekar. Bhavaprakasha of Bhavamishra. 
Volume 1. Varanasi: Chowkamba Sanskrit Series 
Office; 2004. p. 382 
13. A.Rama Murthy, Bidhan Mahajan. Medicinal 
Importance of Darbha- A review. Journal of 
Ayurvedic and Herbal Medicine. 2016; 2(3):89-
95  
14. Rishikesh, Moshfiqur Rahman, Rasheful Goffar, 
Muhammad Rakib Al Mamun, Parboti Rani 
Dutta, Abdullah Al Maruf. Phytochemical and 
Pharmacological Investigation of Achyranthus 
Aspera Linn. Scholars Academic Journal of 
Pharmacy. 2013; 2(2): 74-80  
15. Chhatre S, Nesari T, Somani G, Kanchan D, 
Sathaye S. Phytopharmacological overview of 
Tribulus terrestris. Phcog Rev. 2014;8:45‑51. 
16. Aruna Adepu, Sagar Narala, Ashok Ganji, Sapnil 
Chilvalvar. Areview on Natural Plant: Aerva 
Lanata. International Journal of Pharma 
Sciences. Vol 3, No. 6 (2013):398-402.  
17. P K Warrier, V P K Nambiar, C Ramankutty. 
Indian Medicinal Plants, Volume 5. Hyderabad; 
Orient Longman; p. 44 
18. Sarvani Manthri, Chaitanya Sravanthi Kota, 
Manjula Talluri. Pharmacognostic, 
Phytochemical and Pharmacological Review of 
Dendropthoe Falcata. Journal of Phytology 
2011,3(3):18-25.  
19. Mostafizur Rahman, Jayanta Kishor 
Chakrabarty, Abdul Muhit, Pritesh Ranjan Dash. 
Evaluation of Analgesic Activity of the Different 
Fractions of Typha Elephentina Roxb. 
International Journal of Pharmacognosy; 2014, 
Vol 1 (6):380-383.  
 
 
 
 
 
 
 
 
 
Disclaimer: IJAPR is solely owned by Mahadev Publications - dedicated to publish quality research, while every effort has been taken 
to verify the accuracy of the content published in our Journal. IJAPR cannot accept any responsibility or liability for the articles 
content which are published. The views expressed in articles by our contributing authors are not necessarily those of IJAPR editor or 
editorial board members.  
*Address for correspondence 
Dr Aryamol A D 
Post Graduate Scholar, 
Department of Kayachikitsa,  
Sri Sri College of Ayurvedic 
Science and Research,  
Bengaluru, Karnataka, India. 
Email: 
draryavaidyanath.ayu@gmail.com   
 
 
Cite this article as:  
Aryamol A D, Umesh C, Gopal Krishna G. A Comparative Clinical Study To 
Evaluate The Effect of Charakokta Mutravirechaniya Mahakashaya in 
Mutrakrichra or Lower Urinary Tract Infection. International Journal of 
Ayurveda and Pharma Research. 2020;8(8):39-45. 
Source of support: Nil, Conflict of interest: None Declared 
 
